IMDX Competitors & Alternatives
Compare Insight Molecular Diagnostics Inc. with similar stocks in the same industry
Diagnostics & Research
IMDX
Main Stock$5.08
Tradestie Score
53
Market Cap
$94.16M
Revenue Growth
-1.0%
Analyst Upside
+64.0%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$28.51
|
$798.40M | - | 58 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.55
|
$719.31M | - | 61 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.83
|
$719.23M | - | 58 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$23.72
|
$667.77M | - | 59 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$14.07
|
$612.76M | - | 60 | Compare |
|
LCTX
Lineage Cell Therapeutics, Inc.
|
$1.28
|
$385.92M | - | 52 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$33.49
|
$62.81M | - | 53 | Compare |
|
SYBX
Synlogic, Inc. Common Stock
|
$0.56
|
$19.89M | - | 37 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$2.74
|
$4.78M | - | 47 | Compare |
|
CLSDQ
CLSDQ
|
- | - | - | - | Compare |
More IMDX Analysis
Data updated: Jul 13, 2026 | Industry: Diagnostics & Research (SIC 2835)
40 stocks in this industry